{
  "event_id": "1fbb75cae32c",
  "ticker": "GSK",
  "company_name": "GlaxoSmithKline",
  "drug_name": "Linerixibat",
  "pdufa_date": "2026-03-24",
  "approval_type": {
    "status": "found",
    "value": "nda",
    "source": "websearch:GLISTEN Phase 3 (PDUFA Mar 2026)",
    "confidence": 0.9,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-09T20:53:01.010775",
    "error": null
  },
  "indication": {
    "status": "found",
    "value": "Cholestatic pruritus in PBC",
    "source": "websearch:GLISTEN Phase 3 (PDUFA Mar 2026)",
    "confidence": 0.85,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-09T20:53:01.010776",
    "error": null
  },
  "generic_name": {
    "status": "found",
    "value": "linerixibat",
    "source": "websearch_fda",
    "confidence": 0.85,
    "tier": 2,
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-10T07:18:32.440880",
    "error": null
  },
  "therapeutic_area": {
    "status": "found",
    "value": "Gastroenterology",
    "source": "websearch",
    "confidence": 0.85,
    "tier": 2,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-10T10:49:58.763466",
    "error": null
  },
  "phase": {
    "status": "found",
    "value": "Phase 3",
    "source": "websearch_clinical",
    "confidence": 0.85,
    "tier": 2,
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-10T07:18:32.440880",
    "error": null
  },
  "primary_endpoint_met": {
    "status": "found",
    "value": true,
    "source": "websearch:GLISTEN Phase 3 (PDUFA Mar 2026)",
    "confidence": 0.95,
    "evidence": [
      "GLISTEN Phase 3 (PDUFA Mar 2026)"
    ],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-09T20:53:01.010761",
    "error": null
  },
  "p_value": {
    "status": "found",
    "value": "0.001",
    "source": "websearch:GLISTEN Phase 3 (PDUFA Mar 2026)",
    "confidence": 0.9,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-09T20:53:01.010769",
    "error": null
  },
  "p_value_numeric": 0.001,
  "effect_size": {
    "status": "found",
    "value": "LS mean -0.72 (WI-NRS scale)",
    "source": "websearch:GLISTEN Phase 3 (PDUFA Mar 2026)",
    "confidence": 0.85,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-09T20:53:01.010771",
    "error": null
  },
  "safety_signal": {
    "status": "not_searched",
    "value": null,
    "source": null,
    "confidence": 0.0,
    "evidence": [],
    "searched_sources": [],
    "last_searched": null,
    "error": null,
    "_reset_reason": "Was inferred from: pending_or_withdrawn",
    "_reset_at": "2026-01-09T23:49:24.204703"
  },
  "phase3_study_names": [
    "Long-term Safety and Tolerability Study of Linerixibat for the Treatment of Cholestatic Pruritus in Participants With Primary Biliary Cholangitis"
  ],
  "nct_ids": [
    "NCT04167358"
  ],
  "enrollment": {
    "value": 245,
    "status": "found",
    "source": "clinicaltrials.gov",
    "confidence": 0.95,
    "tier": 2
  },
  "has_prior_crl": {
    "status": "found",
    "value": true,
    "source": "derived_from_resubmission",
    "confidence": 0.85,
    "tier": 2
  },
  "prior_crl_reason": null,
  "is_resubmission": {
    "status": "found",
    "value": true,
    "source": "legacy_v12",
    "confidence": 0.75,
    "evidence": [],
    "searched_sources": [
      "legacy_v12"
    ],
    "last_searched": null,
    "error": null
  },
  "pai_passed": {
    "status": "not_searched",
    "value": null,
    "source": null,
    "confidence": 0.0,
    "evidence": [],
    "searched_sources": [],
    "last_searched": null,
    "error": null,
    "_reset_reason": "Was inferred from: pending_or_withdrawn",
    "_reset_at": "2026-01-09T23:49:24.204703"
  },
  "warning_letter": {
    "status": "not_searched",
    "value": null,
    "source": null,
    "confidence": 0.0,
    "evidence": [],
    "searched_sources": [],
    "last_searched": null,
    "error": null,
    "_reset_reason": "Was inferred from: pending_or_withdrawn",
    "_reset_at": "2026-01-09T23:49:24.204703"
  },
  "result": "pending",
  "data_quality_score": 0.075,
  "collected_at": "2026-01-09T00:44:00.357006",
  "enriched_at": "2026-01-11T18:52:20.807865",
  "needs_manual_review": false,
  "review_reasons": [],
  "original_case_id": "9f371f76a186",
  "fda_designations": {
    "breakthrough_therapy": true,
    "fast_track": true,
    "priority_review": true,
    "orphan_drug": true,
    "accelerated_approval": false
  },
  "mechanism_of_action": "IBAT inhibitor",
  "adcom_info": {
    "scheduled": false,
    "held": false,
    "outcome": null,
    "vote": null
  },
  "days_to_pdufa": 73,
  "pdufa_status": "upcoming",
  "risk_tier": "MEDIUM",
  "days_calculated_at": "2026-01-10T16:59:39.665936",
  "is_single_arm": {
    "value": true,
    "status": "found",
    "source": "clinicaltrials.gov",
    "confidence": 0.95,
    "tier": 2,
    "evidence": [
      "interventionModel=SINGLE_GROUP",
      "allocation=NA"
    ],
    "searched_sources": [
      "clinicaltrials.gov"
    ],
    "last_searched": "2026-01-11T08:31:08.931161",
    "error": null,
    "note": null,
    "has_value": true,
    "needs_retry": false,
    "is_complete": true
  },
  "trial_region": {
    "value": "global",
    "status": "found",
    "source": "clinicaltrials.gov",
    "confidence": 0.95,
    "tier": 2,
    "evidence": [
      "countries=['MEXICO', 'SPAIN', 'UNITED KINGDOM', 'ISRAEL', 'JAPAN']..."
    ],
    "searched_sources": [
      "clinicaltrials.gov"
    ],
    "last_searched": "2026-01-11T08:31:08.931201",
    "error": null,
    "note": null,
    "has_value": true,
    "needs_retry": false,
    "is_complete": true
  },
  "adcom_scheduled": {
    "value": false,
    "status": "confirmed_none",
    "source": "websearch_adcom",
    "confidence": 0.7,
    "tier": 3,
    "evidence": [],
    "searched_sources": [
      "websearch_adcom"
    ],
    "last_searched": "2026-01-11T08:38:27.731631"
  },
  "adcom_vote_ratio": {
    "value": null,
    "status": "not_applicable",
    "source": "websearch_adcom",
    "confidence": 0.6,
    "tier": 3,
    "evidence": [],
    "searched_sources": [
      "websearch_adcom"
    ],
    "last_searched": "2026-01-11T08:38:27.731639"
  },
  "breakthrough_therapy": {
    "value": null,
    "status": "not_found",
    "source": "websearch",
    "confidence": 0.0,
    "tier": 3,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-11T18:52:01.403247",
    "search_status": "CONFIRMED_NONE"
  },
  "orphan_drug": {
    "value": true,
    "status": "found",
    "source": "websearch",
    "confidence": 0.75,
    "tier": 2,
    "evidence": [
      "Linerixibat New Drug Application (NDA) accepted for ... - GSK"
    ],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-11T18:52:02.810642",
    "search_status": "FOUND"
  },
  "priority_review": {
    "value": null,
    "status": "not_found",
    "source": "websearch",
    "confidence": 0.0,
    "tier": 3,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-11T18:52:08.529917",
    "search_status": "CONFIRMED_NONE"
  },
  "fast_track": {
    "value": null,
    "status": "not_found",
    "source": "websearch",
    "confidence": 0.0,
    "tier": 3,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-11T18:52:15.252075",
    "search_status": "CONFIRMED_NONE"
  },
  "accelerated_approval": {
    "value": null,
    "status": "not_found",
    "source": "websearch",
    "confidence": 0.0,
    "tier": 3,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-11T18:52:20.807848",
    "search_status": "CONFIRMED_NONE"
  }
}